171 related articles for article (PubMed ID: 2211716)
1. Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa.
Kirchhofer D; Gailit J; Ruoslahti E; Grzesiak J; Pierschbacher MD
J Biol Chem; 1990 Oct; 265(30):18525-30. PubMed ID: 2211716
[TBL] [Abstract][Full Text] [Related]
2. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).
Du XP; Plow EF; Frelinger AL; O'Toole TE; Loftus JC; Ginsberg MH
Cell; 1991 May; 65(3):409-16. PubMed ID: 2018974
[TBL] [Abstract][Full Text] [Related]
3. Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor.
Beer JH; Springer KT; Coller BS
Blood; 1992 Jan; 79(1):117-28. PubMed ID: 1728303
[TBL] [Abstract][Full Text] [Related]
4. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
[TBL] [Abstract][Full Text] [Related]
5. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets.
Lam SC; Plow EF; Smith MA; Andrieux A; Ryckwaert JJ; Marguerie G; Ginsberg MH
J Biol Chem; 1987 Jan; 262(3):947-50. PubMed ID: 3805026
[TBL] [Abstract][Full Text] [Related]
6. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.
Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J
Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688
[TBL] [Abstract][Full Text] [Related]
7. Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites.
Smith JW; Ruggeri ZM; Kunicki TJ; Cheresh DA
J Biol Chem; 1990 Jul; 265(21):12267-71. PubMed ID: 2373693
[TBL] [Abstract][Full Text] [Related]
8. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
Bennett JS; Shattil SJ; Power JW; Gartner TK
J Biol Chem; 1988 Sep; 263(26):12948-53. PubMed ID: 3417645
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides demonstrate RGD-independent platelet glycoprotein IIb/IIIa recognition site in cell binding domain of human fibronectin.
Mohri H; Tanabe J; Katoh K; Okubo T
Peptides; 1995; 16(2):263-8. PubMed ID: 7784256
[TBL] [Abstract][Full Text] [Related]
10. Arg-Gly-Asp-dependent occupancy of GPIIb/IIIa by applaggin: evidence for internalization and cycling of a platelet integrin.
Wencel-Drake JD; Frelinger AL; Dieter MG; Lam SC
Blood; 1993 Jan; 81(1):62-9. PubMed ID: 8417803
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cation-binding sequences in the platelet integrin GPIIb-IIIa (alpha IIb beta 3) by terbium luminescence.
Cierniewski CS; Haas TA; Smith JW; Plow EF
Biochemistry; 1994 Oct; 33(40):12238-46. PubMed ID: 7522557
[TBL] [Abstract][Full Text] [Related]
13. Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B
Biochem Biophys Res Commun; 1994 Oct; 204(1):325-32. PubMed ID: 7524499
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a chymotryptic fragment of platelet glycoprotein IIb-IIIa retaining Arg-Gly-Asp binding activity.
Lam SC
J Biol Chem; 1992 Mar; 267(8):5649-55. PubMed ID: 1544938
[TBL] [Abstract][Full Text] [Related]
15. Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides.
Peishoff CE; Ali FE; Bean JW; Calvo R; D'Ambrosio CA; Eggleston DS; Hwang SM; Kline TP; Koster PF; Nichols A
J Med Chem; 1992 Oct; 35(21):3962-9. PubMed ID: 1433203
[TBL] [Abstract][Full Text] [Related]
16. Endogenous platelet fibrinogen surface expression on activated platelets.
Gralnick HR; Williams S; McKeown L; Connaghan G; Shafer B; Hansmann K; Vail M; Fenton J
J Lab Clin Med; 1991 Dec; 118(6):604-13. PubMed ID: 1744509
[TBL] [Abstract][Full Text] [Related]
17. Peptides derived from a sequence within beta 3 integrin bind to platelet alpha IIb beta 3 (GPIIb-IIIa) and inhibit ligand binding.
Steiner B; Trzeciak A; Pfenninger G; Kouns WC
J Biol Chem; 1993 Apr; 268(10):6870-3. PubMed ID: 8463215
[TBL] [Abstract][Full Text] [Related]
18. Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa.
Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):785-91. PubMed ID: 7519850
[TBL] [Abstract][Full Text] [Related]
19. The amino acid sequence Gly-Ala-Pro-Leu appears to be a fibrinogen binding site in the platelet integrin, glycoprotein IIb.
Gartner TK; Taylor DB
Thromb Res; 1990 Nov; 60(4):291-309. PubMed ID: 1708172
[TBL] [Abstract][Full Text] [Related]
20. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
